CBPO [China Biologic Products] 6-K: (Original Filing)
[China Biologic Reiterates Full Year 2018 Financial Forecast BEIJING, China – January 7, 2019 – Full year 2018 non-GAAP adjusted income from operations is expected to increase in the range of 0% to 2% in RMB terms and non-GAAP adjusted net income is expected to decrease by 2% to 4% in RMB terms over ]